Skip to main content

Table 1 Some important descriptive demographic, clinical, and laboratory data of the studied diabetic and control groups

From: Health-related quality of life in a group of Egyptian children and adolescents with type 1 diabetes: relationship to microvascular complications

Variables

Diabetic group

n = 60

Mean ± SD

Range

Control group

n = 60

Mean ± SD

Range

Age (years)

13.03 ± 2.78 (8–18)

12.43 ± 2.66 (8–18)

Age of onset of disease (years)

5.68 ± 2.77 (1–12)

 

Disease duration (years)

7.34 ± 4.24 (1–17)

 

Height (cm)

151.23 ± 10.17 (125–167)

150.00 ± 12.51 (120–172)

Weight (kg)

45.29 ± 12.54 (21–70)

42.16 ± 10.46 (22–72)

BMI (kg/m2)

19.33 ± 3.31 (13.4–27.3)

18.35 ± 2.51 (12.1–28.1)

Mean Insulin dose (IU/kg/d)

1.04 ± 0.30 (0.48–1.70)

 

Systolic blood pressure (mmHg)

110.33 ± 10.73 (90–130)

104.58 ± 10.05 (90–120)

Diastolic blood pressure (mmHg)

71.75 ± 9.69 (50–90)

65.00 ± 6.57 (50–80)

MRBG (mg/dl)

214.15 ± 49.94 (105–360)

84.53 ± 9.25 (70–105)

HbAlc (%)

8.88 ± 1.56 (5.6–12.6)

 
  1. SD standard deviation, IU/kg/d international unit per kilogram per day, BMI body mass index, MRBG mean random blood glucose, Mg/dl milligram per deciliter, HbAlc glycated hemoglobin A1C